Oncology

Latest News

The data presented at ASCO reflect patients seen during 2 community health fairs designed to reach underserved populations in Georgia. | Image credit: NIKCOA - stock.adobe.com

Teledermatology Shows Promise to Reduce Disparities in Skin Cancer Screening

June 18th 2025

A teledermatology program in Georgia helped identify patients with skin lesions that warranted in-person follow-up with a physician.

Patients in the cemiplimab group had superior disease-free survival vs placebo. | Image credit: Medical Works - stock.adobe.com

Cemiplimab Improves Disease-Free Survival in High-Risk, Advanced CSCC

By Jared Kaltwasser

June 13th 2025

The approval covers use of pembrolizumab as a single agent in the neoadjuvant setting, followed by adjuvant treatment with pembrolizumab in combination with radiotherapy with or without cisplatin after surgery, and then continued as a single agent. | Image credit: wladimir1804-stock.adobe.com

FDA Approves Perioperative Pembrolizumab in Resectable HNSCC

By Jordyn Sava

June 13th 2025

FDA approval-Olivier Le Moal-stock.adobe.com.jpeg

Mitomycin Intravesical Solution Gains FDA Approval for Recurrent Low-Grade NMIBC

By Giuliana Grossi

June 12th 2025

Utilization and Costs Among Oncologists Participating in a Private Insurance Shared Savings Model

By Brigham Walker, PhD
Lalan Wilfong, MD

June 11th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

May 14th 2015

ASCO Annual Meeting Promises to Deliver on Important Cancer Advances

Surabhi Dangi-Garimella, PhD

Yesterday, the American Society of Clinical Oncology (ASCO) lifted the embargo on nearly 5000 abstracts that will be presented at ASCO's 51st Annual Meeting to be held in Chicago, May 29-June 2. The results from a few of the studies were released via a presscast that saw participation by the chair of ASCO's clinical communications committee, the current ASCO president, and the ASCO president-elect.

May 13th 2015

Number of Patients on High Cost Specialty Medications Sky-Rocketing

The prices for new hepatitis C and cancer treatments are driving the cost of prescription drugs to new highs for more Americans, according to a new report, which found that 9 of 10 patients with drug costs of $50,000 or more used specialty drugs.

May 13th 2015

Next Generation ACO Model and Oncology Medical Home Model

May 13th 2015

Accountable Care Organizations in Oncology

May 13th 2015

Improving Quality Measures in Oncology

May 13th 2015

Stakeholder Voice in Developing Oncology Payment Models

May 13th 2015

Surgeons More Selective With Surgeries in Late-Stage Cancer Patients

A study published in the Journal of Surgical Research has found that surgeons are focusing on life-enhancing procedures for late-stage cancer patients. In their follow-up on 22,000 late-stage cancer patients in the United States between 2006 and 2010, while the use of surgeries declined only slightly, doctors became more likely to restrict surgery to healthier patients.

May 12th 2015

Blood-Based Proteomic Test for NSCLC Will Be Reimbursed by UnitedHealthcare

The diagnostic test, developed by Biodesix, Inc, will help guide treatment decisions in patients with advanced lung cancer.

May 12th 2015

New HPV Vaccine Can Protect Against 80% of Cervical Cancers, Study Estimates

The study, published in the Journal of the National Cancer Institute found that in addition to protecting against 80% of cervical cancers, the new Gardasil-9 has the potential to protect against nearly 19,000 other cancers diagnosed in the United States.

May 11th 2015

Parent Belief Determines HPV Vaccination Rates in Young Girls, Study Finds

Based on their analysis of a mail-in questionnaire, researchers in Canada found that parents who had their daughters vaccinated differed from those who did not do so in perceived susceptibility to the disease, benefits and barriers of the vaccine, and cues to action.

May 11th 2015

To Improve Personalized Oncology Care, Cancer Centers Collaborate With IBM

In collaborations with 14 cancer centers throughout the country, IBM will apply Watson Genomic Analytics, a cloud-based service, to implement evidence-based treatment decisions in oncology.

May 9th 2015

Managed Care Minute: May 9, 2015

A one-minute look at managed care news during the week of May 4, 2015, including global cancer drug spend, movements in telehealth, and changing behavior to reverse poor health.

May 8th 2015

Breast, Cervical, Colorectal Cancer Screenings Below Target, CDC Reports

Laura Joszt, MA

Overall, regular breast, cervical, and colorectal cancer screening was below target in 2013, according to a new report from the CDC. In fact, researchers found overall screening in these 3 areas showed no improvements from 2010 to 2013.

May 8th 2015

Dr Crystal Denlinger Describes the 3 Challenges Facing Cancer Survivors

There are 3 general issues that cancer survivors face, and each of them are very different challenges, according to Crystal S. Denlinger, MD, from the Fox Chase Cancer Center in Philadelphia.

May 8th 2015

Hepatitis C Drugs on WHO's "Essential Medicines" List

The addition by the World Health Organization follows requests by consumer groups for the agency to widen its list to include some of the latest treatments carrying high price tags.

May 8th 2015

Study Says Second Opinions Matter in Breast Cancer Pathology

The Roswell Park pathology team reviewed 500 breast core biopsy cases provided by referring institutions in a single calendar year and found that 8% of the cases had a major discordance and 13% had a minor discordance, especially with respect to interpreting biomarkers that determine prognosis and therapeutic options.

May 8th 2015

Dublin-Based Amarin Pharma Sues FDA Over Transparency on Off-Label Drug Use

Amarin's action has initiated a debate on whether the FDA's authority over ensuring the safety and efficacy is being side-stepped.

May 8th 2015

Amgen Appeal Will Delay Marketing of Novartis Biosimilar

The appeals court decision has ensured that Novartis cannot bring its biosimilar Zarxio (filgrastim), which provides immune support to cancer patients, to the market at least till June 3.

May 7th 2015

Why Oncologists Are Skeptical About CMS' New Payment Model

Since the introduction of the Oncology Care Model, oncologists have raised numerous questions as they weigh whether to apply for participation.

May 7th 2015

Study Points to Improved PFS in Prostate Cancer Patients on Statin Therapy

The study conducted by researchers at Dana-Farber Cancer Institute, and published in JAMA Oncology, found a siginificant increase in progression-free survival in men who initiated statin therapy along with androgen deprivation for their prostate cancer.

May 6th 2015

Alex Bastian Discusses the Financial Burden Cancer Patients Bear

Costs have a huge impact on patients and financial toxicity, particularly in cancer care, is being given greater consideration now, according to Alex Bastian, MBA, senior vice president at GfK.

May 6th 2015

Surgery for Terminally Ill Cancer Patients Remains Prevalent

Laura Joszt, MA

Although 30-day morbidity and mortality all declined incrementally for terminally ill cancer patients undergoing surgical intervention from 2006-2010, the number of surgeries remains high, according to a study from University of California, Davis Health System.

May 5th 2015

Pharma Seeks Early Price Discussions With Payers

The pharmaceutical industry has learnt its lesson from the pushback that Gilead faced over the price of its hepatitis C drug, Sovaldi. The lack of a price discussion prior to the introduction of the regimen washed-out the excitement over a "cure" for the disease.

May 5th 2015

Cancer Drug Spending Reached $100 Billion Globally in 2014

Laura Joszt, MA

Earlier diagnosis, longer treatment duration, and increased effectiveness of cancer therapies all contributed to the constantly rising spending levels for these medicines.

May 4th 2015

With Advances in Gene Sequencing, Myriad Faced With Strong Competition

Myriad continues its fight to retain customers in its core BRCA testing business, and doctors who have stayed loyal say one of Myriad's biggest advantages is its private database of test results.

May 4th 2015

Stakeholder Challenges With Oral Oncolytics

Patient access, supply chain, adherence, and comorbidities are only a few of the challenges associated with oral anticancer agents, which are included distributed by specialty pharmacies.

May 2nd 2015

Statin Use Lower Risk of Lung Cancer Death

Lung cancer patients who used statins in the year prior to a lung cancer diagnosis or after a lung cancer diagnosis had a reduction in the risk of death from the disease.

May 1st 2015

Challenges With Including PROs in Oncology Product Labels

The debate over including patient reported outcomes on oncology drug labels continues. The FDA expects well-defined and validated measurement tools and the patient community wants patient experiences to find their way to the label.

May 1st 2015

Express Scripts Eyeing Pricey Cancer Drugs Next

Pharmacy benefit manager Express Scripts Holding Co, which has aggressively negotiated lower costs of new hepatitis C drugs, on Wednesday said a new "focus area" will be subduing costs of a growing wave of pricey biotech cancer drugs.

April 30th 2015

Independent Committee Recommends T-Vec for Approval Despite FDA Staff Concerns

Amgen might be the latest entrant in the immunotherapy realm if the FDA heeds the advice of an independent advisory panel, recommending Amgen's anticancer viral therapy, T-Vec, for melanoma treatment.

...

130 131 132 133 134 135 136 137 138

...

186 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions